Welcome, please Login here

About Prozomix

Advancing Biocatalysis

Prozomix Limited is a privately owned research orientated UK biotechnology company that develops, produces and supplies a large, diverse and rapidly expanding range of novel enzymes and related advanced products and services for Biocatalysis and other focus areas, such as Biofuels and the Biorefinery.

In 2011, Prozomix launched a Biocatalysis Enzyme Toolkit, comprising novel panels of advanced biocatalysts, targeted towards the synthetic organic chemist.  Each panel was populated Biocatalyst Contract Manufacturing Solutionsusing a rational expansion bioinformatics approach, ensuring representative enzymes effectively sample the hugely diverse range of specificities and biophysical properties afforded by nature, and increasingly desired in biocatalysis applications.  Additionally, each panel is continuously expanded in order to keep pace with the ever expanding genomics resource, thus ensuring maximum exploitation of known / visible sequence space.  When a suitable enzyme(s) has been identified against a target biotransformation, Prozomix offers a full range of contract manufacturing solutions, catering for any grade and formulation of enzyme all the way up to multi-ton scale.  Alternatively, under the Biocatalysis Enzyme Toolkit agreement, at this stage the customer is free to use any other third party contract manufacturing service entirely at their discretion.

The Prozomix web site (www.prozomix.com) ensures an efficient and transparent purchasing experience, where most products are available in off-the-shelf format with just 1-2 days delivery globally via UPS.  With respect to our recombinant research enzymes, not only is our range BLAST searchable, but primary sequences are freely available and easily accessible for most products.  Another notable feature of our web site is our Commercial Academic Partner (CAP) Programme, which enables rapid and efficient commercialisation of enzyme encoding plasmids, in exchange for a generous royalty of 17.5 %.

Our strength is not just our novel enzyme technology, but the 365 days-a-year rapid technical support that fully backs it up.  Such comprehensive technical support, as appreciated by today’s applications and research scientist, is enabled by our very experienced Research and Development Team.